INVESTIGATION OF POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) AS A NOVEL THERAPEUTIC TARGET IN SMALL CELL LUNG CANCER (SCLC)

被引：0
|
作者：
Byers, Lauren A. [1 ]
Nilsson, Monique [1 ]
Fujimoto, Junya [1 ]
Saintigny, Pierre [1 ]
Wang, Jing [1 ]
Diao, Lixia [1 ]
Peyton, Michael [2 ]
Fan, You-Hong [1 ]
Giri, Uma [1 ]
Weber, Stephanie [2 ]
Duchemann, Boris [1 ]
Girard, Luc [2 ]
Coombes, Kevin [1 ]
Weinstein, John [1 ]
Minna, John D. [2 ]
Wistuba, Ignacio [1 ]
Heymach, John V. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
SCLC; PARP1; Large cell neuroendocrine;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1530 / S1531
页数：2
相关论文
共 50 条
  • [21] Design, synthesis, and biological evaluation of novel chrysin derivatives as poly(ADP-ribose) polymerase 1(PARP1) inhibitors for the treatment of breast cancer
    YANG Yao
    TONG Jing
    XIE Xianshun
    CAO Hong
    FU Yong
    LUO Yong
    LIU Shan
    CHEN Wen
    YANG Ning
    Chinese Journal of Natural Medicines, 2024, 22 (05) : 455 - 465
  • [22] Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer A Review
    Guo, Matthew Z.
    Marrone, Kristen A.
    Spira, Alexander
    Scott, Susan C.
    CANCER JOURNAL, 2021, 27 (06): : 476 - 481
  • [23] Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma
    Ferrarotto, Renata
    Cardnell, Robert
    Su, Shirley
    Diao, Lixia
    Eterovic, A. Karina
    Prieto, Victor
    Morrisson, William H.
    Wang, Jing
    Kies, Merrill S.
    Glisson, Bonnie S.
    Byers, Lauren Averett
    Bell, Diana
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (08): : 1676 - 1684
  • [24] Poly(ADP-ribose) polymerase: a new therapeutic target?
    Geroe, Domokos
    Szabo, Csaba
    CURRENT OPINION IN ANESTHESIOLOGY, 2008, 21 (02) : 111 - 121
  • [25] Poly(ADP-ribose) Polymerase 1 (PARP1) Expression in iTreg Plays a Role in the Pathogenesis of Experimental Colitis
    Larmonier, Claire B.
    Shehab, Kareem W.
    McFadden, Rita-Marie T.
    Jamwal, Deepa R.
    Kiela, Pawel R.
    Ghishan, Fayez K.
    GASTROENTEROLOGY, 2015, 148 (04) : S326 - S326
  • [26] Poly (ADP-ribose) polymerase 1 (PARP1) inhibition promotes pulmonary metastasis of osteosarcoma by ezrin phosphorylation
    Li, Fangfei
    Wu, Xiaoqiu
    Fu, Xuekun
    Liu, Jin
    Song, Wangze
    Xiao, Gary Guishan
    Lu, Aiping
    Zhang, Ge
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (03): : 1238 - 1253
  • [27] Poly(ADP-Ribose)Polymerase-1 (PARP1) Controls Adipogenic Gene Expression and Adipocyte Function
    Erener, Sueheda
    Hesse, Mareike
    Kostadinova, Radina
    Hottiger, Michael O.
    MOLECULAR ENDOCRINOLOGY, 2012, 26 (01) : 79 - 86
  • [28] Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy
    Cepeda, Victoria
    Fuertes, Miguel A.
    Castilla, Josefina
    Alonso, Carlos
    Quevedo, Celia
    Soto, Manual
    Perez, Jose M.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2006, 1 (01) : 39 - 53
  • [29] Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines
    Ogino, Hideki
    Nakayama, Robert
    Sakamoto, Hiromi
    Yoshida, Teruhiko
    Sugimura, Takashi
    Masutani, Mitsuko
    CANCER GENETICS AND CYTOGENETICS, 2010, 197 (01) : 8 - 15
  • [30] Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines
    Gangopadhyay, Nupur N.
    Luketich, James D.
    Opest, Amy
    Visus, Carmen
    Meyer, Ernest M.
    Landreneau, Rodney
    Schuchert, Matthew J.
    CANCER INVESTIGATION, 2011, 29 (09) : 608 - 616
12345